Wells Fargo’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05K | Sell |
1,443
-28,099
| -95% | -$20.3K | ﹤0.01% | 5840 |
|
|
2025
Q1 | $25.4K | Buy |
29,542
+646
| +2% | +$556 | ﹤0.01% | 5173 |
|
|
2024
Q4 | $48.5K | Buy |
28,896
+2,864
| +11% | +$4.81K | ﹤0.01% | 5003 |
|
|
2024
Q3 | $74.2K | Buy |
26,032
+4,326
| +20% | +$12.3K | ﹤0.01% | 4784 |
|
|
2024
Q2 | $50.8K | Buy |
21,706
+3,565
| +20% | +$8.34K | ﹤0.01% | 4921 |
|
|
2024
Q1 | $53.3K | Buy |
18,141
+2,291
| +14% | +$6.74K | ﹤0.01% | 4856 |
|
|
2023
Q4 | $47.4K | Buy |
15,850
+3,070
| +24% | +$9.18K | ﹤0.01% | 4876 |
|
|
2023
Q3 | $40.4K | Sell |
12,780
-6,750
| -35% | -$21.3K | ﹤0.01% | 4940 |
|
|
2023
Q2 | $75.6K | Buy |
19,530
+10,739
| +122% | +$41.6K | ﹤0.01% | 4934 |
|
|
2023
Q1 | $24.4K | Buy |
8,791
+8,491
| +2,830% | +$23.5K | ﹤0.01% | 5249 |
|
|
2022
Q4 | $540 | Sell |
300
-137
| -31% | -$247 | ﹤0.01% | 6040 |
|
|
2022
Q3 | $1K | Sell |
437
-492
| -53% | -$1.13K | ﹤0.01% | 6069 |
|
|
2022
Q2 | $3K | Buy |
929
+629
| +210% | +$2.03K | ﹤0.01% | 5898 |
|
|
2022
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 6475 |
|
|
2021
Q4 | $2K | Sell |
300
-312
| -51% | -$2.08K | ﹤0.01% | 6338 |
|
|
2021
Q3 | $4K | Buy |
612
+312
| +104% | +$2.04K | ﹤0.01% | 6110 |
|
|
2021
Q2 | $3K | Sell |
300
-100
| -25% | -$1K | ﹤0.01% | 6130 |
|
|
2021
Q1 | $6K | Buy |
+400
| New | +$6K | ﹤0.01% | 6088 |
|